Australia’s National Medicines Policy Review Committee publishes a draft National Medicines Policy (NMP)

Feb 2, 2022

Australia’s National Medicines Policy Review Committee published a draft National Medicines Policy (NMP).  The original NMP was established in 2000, with the stated aim of achieving both ‘optimal health outcomes and economic objectives’.  The scope of the new NMP is proposed to be broadened to encompass biologic medicines, gene therapies, cell and tissue engineered products, and vaccines.

Print Page Mail Article